Executive Summary: The United Kingdom appears to have greater utilization of Durable Medical Equipment (DME) products as compared to the US Medicare Population (over half of the UK vs 21 percent of the US Medicare population). However, this variation in utilization may be driven by definitions rather than patient need. The definition of DME varies … Continue reading
Executive Summary: On January 8th, 2024 the Senate Committee on Health, Education, Labor, and Pensions (HELP) sent letters to the CEOs of the four largest manufacturers of inhalers sold in the United States (AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline (GSK), and Teva) launching an investigation into the high price of inhalers used for Asthma and Chronic Obstructive … Continue reading
Executive Summary: The Biden administration has encouraged states to use Medicaid funds to alleviate the homelessness crisis with around 20 states directing billions of dollars from their Medicaid program to provide short-term housing for those experiencing homelessness, with some states devoting anywhere from six to fifteen percent of its Medicaid spending to such programs. In … Continue reading
Executive Summary: The Center for Medicare and Medicaid Innovation Center’s recent evaluation report of the first year of implementation of the Maternal Opioid Misuse (MOM) Model has yet to deliver any meaningful data due to low participation. Substance Abuse is now the leading cause of maternal mortality in the United States and models like MOM … Continue reading
